ArticleThe Journal of clinical investigation2019

An adapted anti-CTLA4 therapeutic aimed at mitigating the toxicities of checkpoint inhibition.

Jarushka Naidoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.